Abstract
Vascular anomalies are common in the head and neck, and oral lesions are most commonly
found on the lips, tongue, mucosa, and palate. Monoethanolamine oleate sclerotherapy
(MOS) is an option for treatment, although we know of no established protocols yet.
We report the prevalence and characteristics of intraoral vascular anomalies (IVA)
and the results achieved with the use of 5% MOS, and suggest a clinical guideline.
Data from the medical records of patients with IVA were collected (age, sex, ethnicity,
site, size, duration, and treatment). Cases treated with MOS were detailed, and data
about number of applications, interval between them, dose, adverse effects, and results
were recorded. A total of 65 cases of IVA were found. White-skinned women aged from
61 to 70 years (n = 21) were most likely to be affected, and the lower lip (n = 25) was the most common site. Twenty-seven were treated with MOS using a mean of 1–2
applications with a seven-day interval. The mean dose applied was 0.3 ml/section, which was diluted in local anaesthetic in 38 cases. Twenty-two resolved
completely. In summary, we found a prevalence of 4.8% of IVA and European women aged
61 to 70 years were most affected. MOS 5% was effective and safe in the treatment
of IVA more than 3 cm in size, with minimal morbidity and adverse effects. We therefore suggest a sclerotherapy
protocol of 0.3 ml of the drug (undiluted with anaesthetic) for each 1 cm lesion (maximum 3 cm), with weekly revaluations and further applications when necessary within a 14-day
period.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to British Journal of Oral and Maxillofacial SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Venous malformations of the head and neck: current concepts in management.Br J Oral Maxillofac Surg. 2017; 55: 3-9
- Experience with 5% ethanolamine oleate for sclerotherapy of oral vascular anomalies: a cohort of 15 consecutive patients.J Craniomaxillofac Surg. 2019; 47: 106-111
- Superficial venous malformations of the head and neck.Rev Stomatol Chir Maxillofac Chir Orale. 2015; 116 (paper in French): 201-208
- ISSVA classification.Semin Pediatr Surg. 2014; 23: 158-161
- The role of fine-needle aspiration biopsy in the diagnosis and management of juvenile hemangioma of the parotid gland and cheek.Arch Pathol Lab Med. 2001; 125: 1340-1343
- Sclerotherapy with monoethanolamine oleate in benign oral vascular lesions.Minerva Stomatol. 2012; 61: 31-36
- Current concepts in diagnosis and treatment of venous malformations.J Craniomaxillofacial Surg. 2014; 42: 1300-1304
- Interdisciplinary management of head and neck vascular anomalies: clinical presentation, diagnostic findings and minimal invasive therapies.Eur J Radiol Open. 2017; 4: 63-68
- Capillary hemangioma of palatal mucosa.J Indian Soc Periodontol. 2012; 16: 475-478
- Pingyangmycin sclerotherapy for infantile hemangiomas in oral and maxillofacial regions: an evaluation of 66 consecutive patients.Int J Oral Maxillofac Surg. 2011; 40: 1246-1251
- Oral capillary hemangioma: a clinical protocol of diagnosis and treatment in adults.Oral Maxillofac Surg. 2014; 18: 431-437
- Benign oral vascular lesions treated by sclerotherapy with ethanolamine oleate: a retrospective study of 43 patients.Med Oral Patol Oral Cir Bucal. 2018; 23: e180-e187
- Prevalence of oral hemangioma, vascular malformation and varix in a Brazilian population.Braz Oral Res. 2007; 21: 40-45
- Vascular anomalies: hemangiomas.Plast Reconstr Surg. 2002; 110: 572-588
- Superficial arteriovenous hemangioma of the oral cavity.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000; 90: 731-738
- Sclerotherapy for vascular malformations in the oral and maxillofacial region: treatment and follow-up of 66 lesions.J Oral Maxillofac Surg. 2011; 69: e88-e92
- Sclerotherapy in the management of varicose veins and its dermatological complications.Indian J Dermatol Venereol Leprol. 2013; 79: 383-388
- A sclerosant with astringent properties developed in China for oesophageal varices: comparison with ethanolamine oleate and polidocanol.J Gastroenterol Hepatol. 1999; 14: 481-488
- Sclerotherapy of hemangioma with late involution.Dermatol Surg. 2003; 29: 668-671
- Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant.Lancet. 1988; 2: 340-341
- Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: an open clinical trial with 30 lesions.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 100: 579-584
- Anaphylactic reaction to ethanolamine oleate injection in sclerotherapy of esophageal varices.Endoscopy. 1989; 21: 50
- Miller’s anesthesia.7th ed. Churchill Livingstone/Elsevier, Philadelphia2010
Article info
Publication history
Published online: February 11, 2020
Accepted:
January 22,
2020
Received:
April 19,
2019
Identification
Copyright
© 2020 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
